Scilex Holding Company Common Stock(SCLX)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
$29.08
52-Week Range
$4.20 – $34.27
YTD
+122.15%
IV Rank (30D)
0.0
Straddle Price
$2.65
P/C Vol Ratio
0.00
Market Cap
$0.1B
Fair Value

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.53%
Beta vs SPY1.00
Cost of Equity (CAPM)9.28% (VRP-adj)
WACC8.34%
Volatility Risk Premium-144.5pp (IV − HV30), ERP adj -25bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)-4.2%
DCF Horizon10 years explicit + fade
Free Cash Flow (TTM)$-0.0B
Return on Equity (TTM)168.4%
Book / Price-212.6%
Gross Margin (TTM)65.0%
FCF Margin (TTM)-11.3%
Quality Score2/6 — normal (10y DCF)
SMA 50$7.35 (Market Anchor value)
SMA 20 / Bollinger Mid$7.04
Bollinger Width / SMA20754.6% (drives anchor stability)
Net Debt$0.0B
Market Cap$0B
Blended Fair Value
Current Price
$8.70
Deviation
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0%
Peer EV/EBITDA n/a 0%
Peer P/B n/a 0%
Peer P/S n/a 0%
Market Anchor (SMA50) $7.35 0% stability 0% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-06-12 · updated 2026-06-12 09:30:41.186000
Info
Industry (SIC)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) (2836)
Exchange
XNAS
Market Cap
$0.1B

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral …

Price History
Seasonality
MonthAvg ReturnYears of Data
Jan +4.37% 4
Feb +1.66% 4
Mar -4.13% 4
Apr -12.36% 4
May -0.67% 4
Jun +19.56% 4
Jul +37.62% 3
Aug -11.96% 3
Sep -19.48% 3
Oct +6.69% 3
Nov -24.34% 4
Dec -6.80% 4
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $7.14
SMA 50: $7.38
SMA 200: $12.98
Current: $8.50
EMA 12: $7.75
EMA 26: $7.52
MACD: 0.2274 | Signal: 0.1943
BULLISH
ADX (14): 24.31
WEAK TREND
+DI: 32.76
−DI: 13.61
Momentum Oscillators
RSI (14): 57.99
NEUTRAL
Stoch %K: 73.58
Stoch %D: 61.51
Williams %R: -31.72
Volume & Volatility
BB Upper: $9.09
BB Lower: $5.18
NEUTRAL
OBV: 505,085
Vol SMA 20: 100,470
Vol ROC: -68.36%
ATR: $0.93
True Range: $0.79
HV 20: 133.2%
HV 30: 132.1%
HV 60: 122.9%

Data Summary
Data Points: 500
Last Updated: 2026-06-12T21:15:23.039000
Date Range: 2024-06-14T00:00:00 – 2026-06-12T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Earnings History
2 of 2 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-08-01 Pre-Market 322.33% 5.66% 0.02x Within
2024-10-08 Pre-Market 24.19% 6.46% 0.27x Within
Options Activity
IV Rank (30D)
0.0
IV Rank (7D)
0.0
Avg IV
0.0%
Straddle (30D)
$2.65
Straddle (7D)
$2.65
P/C Volume
0.00
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Volatility Surface

Enter a ticker to render the implied volatility surface.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
2.15
Correlation (SPY)
21.7%
0.05
Ann. Volatility
122.4%
SPY Volatility
12.3%

High volatility - stock moves more than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31
Diluted shares outstanding: 11,449,500 (as of 2025-12-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

77 filers874,716 shares$7.79M value7.64% of float
# Filer Shares Value % of Total % of Float Period
1 VANGUARD GROUP INC Custodian 295,024 $3.60M 46.17% 2.58% 2025-12-31
2 ARMISTICE CAPITAL, LLC 297,706 $1.98M 25.44% 2.60% 2026-03-31
3 BlackRock, Inc. Custodian 102,796 $684.62K 8.78% 0.90% 2026-03-31
4 RENAISSANCE TECHNOLOGIES LLC 36,864 $245.51K 3.15% 0.32% 2026-03-31
5 STATE STREET CORP 35,376 $235.60K 3.02% 0.31% 2026-03-31
6 Donald L. Hagan, LLC 11,873 $233.66K 3.00% 0.10% 2025-09-30
7 Ashton Thomas Private Wealth, LLC 17,989 $219.47K 2.82% 0.16% 2025-12-31
8 MORGAN STANLEY Custodian 14,606 $178.19K 2.29% 0.13% 2025-12-31
9 XTX Topco Ltd 22,606 $150.56K 1.93% 0.20% 2026-03-31
10 NORTHERN TRUST CORP Custodian 15,033 $100.12K 1.28% 0.13% 2026-03-31
11 CITIGROUP INC Custodian 8,954 $59.63K 0.77% 0.08% 2026-03-31
12 UBS Group AG Custodian 6,468 $43.08K 0.55% 0.06% 2026-03-31
13 CREATIVE FINANCIAL DESIGNS INC /ADV 1,853 $12.34K 0.16% 0.02% 2026-03-31
14 ROYAL BANK OF CANADA Custodian 1,596 $11.00K 0.14% 0.01% 2026-03-31
15 MetLife Investment Management, LLC 1,090 $7.26K 0.09% <0.01% 2026-03-31
16 DEUTSCHE BANK AG\ Custodian 800 $5.33K 0.07% <0.01% 2026-03-31
17 Versant Capital Management, Inc 761 $5.07K 0.07% <0.01% 2026-03-31
18 JONES FINANCIAL COMPANIES LLLP Custodian 752 $4.82K 0.06% <0.01% 2026-03-31
19 IFP Advisors, Inc Custodian 576 $3.84K 0.05% <0.01% 2026-03-31
20 MCF Advisors LLC 474 $3.16K 0.04% <0.01% 2026-03-31
21 Activest Wealth Management 302 $2.01K 0.03% <0.01% 2026-03-31
22 KLP KAPITALFORVALTNING AS 290 $1.93K 0.02% <0.01% 2026-03-31
23 GAMMA Investing LLC 116 $773 <0.01% <0.01% 2026-03-31
24 OSAIC HOLDINGS, INC. Custodian 98 $639 <0.01% <0.01% 2026-03-31
25 S&T BANK/PA 78 $519 <0.01% <0.01% 2026-03-31
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/B Ratio-0.2
P/S Ratio1.8
EV/EBITDA-0.5
TTM Revenue$0.0B
TTM Net Income$-0.4B
TTM EPS$-36.45
ROE168.4%
Debt/Equity-0.34